 |
PDBsum entry 4l2y
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Signaling protein/transferase/inhibitor
|
PDB id
|
|
|
|
4l2y
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Signaling protein/transferase/inhibitor
|
 |
|
Title:
|
 |
Crystal structure of p110alpha complexed with nish2 of p85alpha and compound 9d
|
|
Structure:
|
 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform. Chain: a. Synonym: pi3-kinase subunit alpha, pi3k-alpha, pi3kalpha, ptdins-3- kinase subunit alpha, phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kda catalytic subunit alpha, ptdins-3-kinase subunit p110-alpha, p110alpha, phosphoinositide-3-kinase catalytic alpha polypeptide, serine/threonine protein kinase pik3ca. Engineered: yes.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: pik3ca. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Gene: grb1, pik3r1.
|
|
Resolution:
|
 |
|
2.80Å
|
R-factor:
|
0.218
|
R-free:
|
0.271
|
|
|
Authors:
|
 |
J.Zhang,Y.L.Zhao,Y.Y.Chen,M.Huang,F.Jiang
|
|
Key ref:
|
 |
Y.Zhao
et al.
(2014).
Crystal Structures of PI3Kα Complexed with PI103 and Its Derivatives: New Directions for Inhibitors Design.
Acs Med Chem Lett,
5,
138-142.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
05-Jun-13
|
Release date:
|
01-Jan-14
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 2:
|
 |
Chain A:
E.C.2.7.11.1
- non-specific serine/threonine protein kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
Chain A:
E.C.2.7.1.137
- phosphatidylinositol 3-kinase.
|
|
 |
 |
 |
 |
 |

Pathway:
|
 |
|
 |
 |
 |
 |
 |
Reaction:
|
 |
a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol) + ATP = a 1,2-diacyl- sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate) + ADP + H+
|
 |
 |
 |
 |
 |
1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol)
|
+
|
ATP
|
=
|
1,2-diacyl- sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate)
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 4:
|
 |
Chain A:
E.C.2.7.1.153
- phosphatidylinositol-4,5-bisphosphate 3-kinase.
|
|
 |
 |
 |
 |
 |

Pathway:
|
 |
|
 |
 |
 |
 |
 |
Reaction:
|
 |
a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate) + ATP = a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5- trisphosphate) + ADP + H+
|
 |
 |
 |
 |
 |
1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate)
|
+
|
ATP
|
=
|
1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5- trisphosphate)
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Acs Med Chem Lett
5:138-142
(2014)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal Structures of PI3Kα Complexed with PI103 and Its Derivatives: New Directions for Inhibitors Design.
|
|
Y.Zhao,
X.Zhang,
Y.Chen,
S.Lu,
Y.Peng,
X.Wang,
C.Guo,
A.Zhou,
J.Zhang,
Y.Luo,
Q.Shen,
J.Ding,
L.Meng,
J.Zhang.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The phosphatidylinositol 3-kinase (PI3K) signaling pathway plays important roles
in cell proliferation, growth, and survival. Hyperactivated PI3K is frequently
found in a wide variety of human cancers, validating it as a promising target
for cancer therapy. We determined the crystal structure of the human
PI3Kα-PI103 complex to unravel molecular interactions. Based on the structure,
substitution at the R1 position of the phenol portion of PI103 was demonstrated
to improve binding affinity via forming a new H-bond with Lys802 at the bottom
of the ATP catalytic site. Interestingly, the crystal structure of the PI3Kα-9d
complex revealed that the flexibility of Lys802 can also induce additional space
at the catalytic site for further modification. Thus, these crystal structures
provide a molecular basis for the strong and specific interactions and
demonstrate the important role of Lys802 in the design of novel PI3Kα
inhibitors.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
|